CEDIC
- Company typePrivate
- Founded2008
- HeadquartersAsunción, Paraguay
- Headcount11–50
- GTM typeB2B
- OfferingServices
CEDIC firmographics
Firmographics- Name
- CEDIC
- Legal name
- Centro para el Desarrollo de Investigación Científica
- Website
- https://cedic.org.py
- Company type
- Private
- Founded year
- 2008
- Operating status
- Operating
- Headcount range
- 11–50 employees
- Ownership category
- akta.pro rank
CEDIC industry classification
Industry- Product category
- Biomedical Research Services
- NAICS
- Medical Laboratories (621511), Research and Development in Biotechnology (except Nanobiotechnology) (541714)
- SIC
- Services-Medical Laboratories (8071), Services-Commercial Physical & Biological Research (8731)
- akta.pro primary industry
- Central Laboratory Services (Core Lab Operations) (HLAGAEAA)
- akta.pro secondary industry
- Central Laboratory & Clinical Trial Testing CROs (HLAGAAAE)
Keywords
Where CEDIC is headquartered
LocationHeadquarters
- HQ city
- Asunción
- HQ country
- Paraguay
- HQ region
- Latin America
Offices1 record
Markets served
CEDIC business model
Business model- GTM type
- B2B
- Offering type
- Services
- Cost components
- Personnel, Operations, Technology or R&D, Infrastructure
Distribution channels2 records
Marketing channels4 records
CEDIC product offering
Product offeringCore offering
CEDIC is a non-profit research center that provides shared laboratory infrastructure and research platforms for independent researchers working in biological sciences, health, and environment. Its services span molecular diagnostics, biobank services, preclinical drug development, antivenom production, and applied research on disease vectors and zoonotic diseases in collaboration with Paraguay's Ministry of Public Health and Social Welfare (MSPBS).
Product overview
CEDIC is a non-profit research center (legally established in 2008) that operates as a research infrastructure provider rather than a traditional product company. The organization offers a unified portfolio of scientific research services centered on its laboratory infrastructure platform, including molecular diagnostic testing services for genetic diseases and cancer, biobank services developed in partnership with Galatea Bio, preclinical drug development services with pharmacological screening capabilities, and antivenom production. These services support independent researchers through various affiliation modalities, enabling work in existing or new research lines focused on the health-environment nexus.
Differentiator
Problem solved
Functional benefit
Products and services
- Molecular Diagnostic Testing Services
Quantifiable outcome
- 85% of world population depends directly on plants for medicine
- +2 more outcomes
Companies that use CEDIC
Customer profileSegments1 record
Ideal customer profiles2 records
CEDIC technology and API
TechnologyAPI detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Feature4 records
CEDIC partnerships and signals
Strategic signalPartnerships
Nine partnerships are on record, tiered core and major.
- ISGlobal / AECIDcoreProject 'Strengthening MSPBS in global fight against Chagas disease' with EU 30,000 funding for one year. Also collaborating on diagnostic validation methodologies.
- GHIT Fund / Fundación Mundo SanocoreValidation of alternative diagnostic methodologies: rapid tests and Chagas-LAMP for detection of chronic and congenital Trypanosoma cruzi infection.
- UNICEF / UNDP / World Bank / WHO TDRcoreMultiple international projects including research on Triatoma infestans reinfestation in Paraguayan Chaco indigenous housing, and Chagas disease vector sources.
- Universidad de Bath (UK)coreDevelopment of genomics toolkit for Chagas Disease surveillance and digital parasitology with open robotic microscopes (Dr Richard Bowman). EU 25,000 funding for publication.
- Arizona State UniversitycoreSocial Networks research project 2008-2010, and genetic diversity analysis of Mycobacterium tuberculosis in Paraguayan Chaco (School of Human Evolution and Social Change, 2010-2014).
- Galatea BiocoreJoint study with Universidad Nacional del Este on COVID-19 and long COVID genetic architecture in Paraguayan population. Galatea Bio (Stanford-affiliated) is developing integrated biobank platform, genomic testing, and advanced analysis capabilities in Paraguay.
- Universitat de les Illes BalearsmajorAutomated detection of Triatoma infestans reinfestation project (2012-2014).
- Fundación Moises BertonimajorProject improving water access for six indigenous communities through autonomous and sustainable systems in Caazapa and Canindeyú, Paraguay.
- BID / Mundo Sano / SENEPAmajorRegional cooperation for promotion of Chagas disease control in the Gran Chaco Sudamericano region.
Scale indicators2 records
Recent moves6 records
Expansion highlights4 records
CEDIC competitors and assessment
Company assessmentRegional players
- CONICET (Argentina): Argentina's national research council supporting biomedical, health, and environmental research across multiple institutes. Comparable as a Latin American public research funding and infrastructure body, though operating at a national-council scale rather than a single research center like CEDIC.
Direct peers
- Instituto Butantan: Brazilian biomedical research institute that operates biotechnological antivenom production, molecular diagnostics, and tropical disease research—directly comparable to CEDIC's antivenom and Chagas/Leishmaniasis programs. Both serve public health missions with similar laboratory infrastructure and translational research models.
- ISGlobal (Barcelona Institute for Global Health): Barcelona-based global health research institute with major programs in Chagas disease and Latin American infectious disease research. ISGlobal is both a CEDIC partner and a direct peer in Chagas diagnostics development and tropical disease translational research.
- CIDEIM (Centro Internacional de Entrenamiento e Investigaciones Médicas): Colombian non-profit biomedical research center focused on infectious diseases of poverty, including Leishmaniasis and Chagas disease. Closely comparable to CEDIC in mission, tropical disease focus, and Latin American non-profit research center structure.
- Institut Pasteur de Montevideo: Uruguayan biomedical research institute within the Institut Pasteur international network, focused on infectious disease research, molecular biology, and vaccine development. Directly comparable to CEDIC in South American non-profit biomedical research center structure and tropical disease focus.
- Instituto Gorgas de Estudios de la Salud: Panamanian biomedical and tropical disease research institute operating as a regional reference laboratory for Central America. Comparable to CEDIC as a Latin American non-profit research center with tropical disease diagnostics and biodiversity research lines.
Broad incumbents
- Swiss Tropical and Public Health Institute (Swiss TPH): Leading European tropical and public health research institute with global programs in Chagas disease, Leishmaniasis, and neglected tropical disease diagnostics. Comparable disease focus to CEDIC but operates at much larger institutional scale with broader global footprint.
- Fiocruz (Fundação Oswaldo Cruz): Brazil's primary public health and biomedical research foundation, conducting tropical disease research, diagnostic development, and reference laboratory services across South America. Comparable in mission and disease focus to CEDIC but operates at dramatically larger scale.
- London School of Hygiene & Tropical Medicine: Major UK-based global health and tropical medicine research institution with extensive Chagas disease and Latin American research programs. Comparable research focus to CEDIC but operates as a globally ranked university and research institution rather than a regional non-profit.
- Bernhard Nocht Institute for Tropical Medicine: German tropical medicine research institute conducting molecular diagnostics, parasitology, and infectious disease research including Chagas disease. Comparable research lines to CEDIC but at significantly larger scale with broader global mandate.
Market position
Strengths4 records
Weaknesses5 records
Competitive moat4 records
Key risks6 records
Key highlights6 records
Customer concentration
CEDIC social profiles
Digital presenceCEDIC financial estimates
Financial estimateRevenue estimate
Valuation estimate
CEDIC leadership team
Management profileNumber of profiles
CEDIC funding detail
Funding detailFunding overview
Funding rounds
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
CEDIC M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about CEDIC
What does CEDIC do?
CEDIC is a non-profit research center that provides shared laboratory infrastructure and research platforms for independent researchers working in biological sciences, health, and environment. Its services span molecular diagnostics, biobank services, preclinical drug development, antivenom production, and applied research on disease vectors and zoonotic diseases in collaboration with Paraguay's Ministry of Public Health and Social Welfare (MSPBS).
Is CEDIC a public or private company?
CEDIC is a private company. It is classified as nonprofit foundation owned and is currently operating.
When was CEDIC founded?
CEDIC was founded in 2008. It employs 11 to 50 people.
Where is CEDIC based?
CEDIC is headquartered in Asunción, Paraguay, in the Latin America region.
Who are CEDIC's main competitors?
CONICET (Argentina) is listed as a regional player. Direct peers are Instituto Butantan, ISGlobal (Barcelona Institute for Global Health), CIDEIM (Centro Internacional de Entrenamiento e Investigaciones Médicas), Institut Pasteur de Montevideo and Instituto Gorgas de Estudios de la Salud. Broad incumbents are Swiss Tropical and Public Health Institute (Swiss TPH), Fiocruz (Fundação Oswaldo Cruz), London School of Hygiene & Tropical Medicine and Bernhard Nocht Institute for Tropical Medicine.
Does CEDIC have an API?
No public API is recorded for CEDIC.
What industry is CEDIC in?
CEDIC's product category is Biomedical Research Services. Its primary akta.pro industry code is HLAGAEAA, Central Laboratory Services (Core Lab Operations), with a secondary code of HLAGAAAE, Central Laboratory & Clinical Trial Testing CROs. Its NAICS code is 621511 and its SIC code is 8071.